In this industry analysis, Scott Mazza, co-founder and COO of Vitality CBD, examines the scientific, legal, and regulatory uncertainties surrounding delta-8 THC as policymakers revisit the Farm Bill. The article explains how delta-8 is synthesized from hemp-derived CBD, outlines early findings on its milder psychoactive profile, and contrasts anecdotal consumer use with the current lack of rigorous clinical research. Mazza argues for science-based regulation focused on production standards and consumer safety, warning that outright prohibition could harm the hemp industry while failing to address the risks posed by poor manufacturing practices.